아토피·피부염

15개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved15 programs
AntibodyCurated CoreFDASanofiApproved

dupilumab (Dupixent, REGN668)

Atopic dermatitis, asthma, CRSwNP, EoE, prurigo nodularis · IL-4Rα

#IL-4R#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 278Status Approved
AntibodyCurated CoreFDAEli LillyApproved

lebrikizumab-lbkz (Ebglyss, LY3650150, lebrikizumab)

Moderate-to-severe atopic dermatitis · IL-13

#IL-13#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 108Status Approved
AntibodyLimited DatastaleUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
AntibodyCurated CorestaleEli Lilly and CompanyApproved

Ixekizumab (Ixekizumab)

Psoriasis; Atopic Dermatitis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 53Status Recruiting
AntibodyCurated CorestaleLEO PharmaApproved

Tralokinumab (Tralokinumab)

Psoriasis; Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 43Status Recruiting
AntibodyLimited DatastaleAlmirall, S.A.Approved

Tildrakizumab (Tildrakizumab)

Psoriasis; Atopic Dermatitis · Psoriasis

#Psoriasis#Antibody#Approved#monoclonal-antibody#AtopicDermatitis+1
Trials 41Status Recruiting
AntibodyCurated CorestaleGalderma R&DApproved

Nemolizumab (Nemolizumab)

Psoriasis; Atopic Dermatitis · Psoriasis

#Psoriasis#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+2
Trials 25Status Recruiting
AntibodyCurated CorestaleRocheApproved

Xolair (Xolair)

Atopic Eczema; Atopic Dermatitis · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 2Status Active
AntibodyLimited DatastaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPhase 1

dupilumab (DUPIXENT®, DUPIXENT® (dupilumab))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPhase 2

REGN3500 + Dupilumab Combo (REGN3500 + Dupilumab Combo)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Phase2#monoclonal-antibody#Sanofi
Trials 1Status Discontinued
AntibodyLimited DatastaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPreclinical

Systemic dupilumab (Systemic dupilumab)

Dermatitis, Atopic · Dermatitis, Atopic

#DermatitisAtopic#Antibody#Preclinical#monoclonal-antibody#Dermatitis+2
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Vanicream- Dupilumab-naïve (Vanicream- Dupilumab-naïve)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Vanicream- Experienced Dupilumab (Vanicream- Experienced Dupilumab)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Active